ArticleClinical cancer research : an official journal of the American Association for Cancer Research2021

BCMA-Specific ADC MEDI2228 and Daratumumab Induce Synergistic Myeloma Cytotoxicity via IFN-Driven Immune Responses and Enhanced CD38 Expression.

Lijie Xing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.